Skip to main content

GOLDMAN SACHS GROUP INC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$103,092
+$25,273 QoQ
Shares Held
93,720
+109.6% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 101 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Sep 30, 2020
CallValue
$0
CallShares
0
PutValue
$2,319,999
PutShares
16,667

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. INO ranks #330 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $103,092 93,720
2026-03-31 $77,819 44,724
2025-12-31 $47,481 27,288
2025-09-30 $125,683 53,711
2025-06-30 $279,018 136,774
2025-03-31 $212,769 130,534
2024-12-31 $531,497 290,436
2024-09-30 $423,037 73,190
2024-06-30 $342,600 42,401
2023-12-31 $17,871 35,042
2023-09-30 $27,768 71,201
2023-06-30 $126,434 280,968
2023-03-31 $1,509,778 1,841,195
2022-12-31 $2,708,924 1,736,491
2022-09-30 $3,935,516 2,274,865
2022-06-30 $2,575,739 1,488,867
2022-03-31 $3,350,475 933,280
2021-12-31 $8,609,365 1,725,324
2021-09-30 $12,577,240 1,756,598
2021-06-30 $12,064,987 1,301,509
2021-03-31 $2,365,851 254,941
2020-12-31 $1,646,666 186,064
2020-09-30 $2,319,999 200,000
2020-09-30 $6,403,222 552,002
2020-06-30 $14,364,295 532,998
2020-03-31 $3,580,276 481,220